New Director Appointed to Armed Forces Medical Affairs Bureau; Four Key Missions Assigned

Lieutenant General Chen Yuan-hao has officially taken the helm as the new Director of the Armed Forces Medical Affairs Bureau, following an appointment ceremony presided over by Deputy Minister of National Defense, General Chung Shu-ming. The transition marks a new chapter for the bureau, with a focus on enhancing the quality and scope of military healthcare services.

General Chung outlined four primary objectives for the bureau under its new leadership. These include strengthening medical resilience, elevating the overall quality of medical care provided to service members, consistently pursuing research and innovation in medical practices, and actively expanding international cooperation and exchange in the medical field. These directives aim to further refine the military's medical capabilities and healthcare support systems.

Chen Yuan-hao is a distinguished figure in the field of neurosurgery, recognized for his expertise in treating brain tumors and spinal conditions, as well as critical care. His extensive career includes leadership roles such as Superintendent of Tri-Service General Hospital, Deputy Director of the Medical Affairs Bureau, and Head of the Health Care Department. His contributions have been acknowledged with the prestigious "Taiwan Medical Model Award."

With over 30 years of experience in military medicine, Chen holds a doctorate from the National Defense Medical Center and has served as a researcher at the U.S. National Institutes of Health. His tenure as Superintendent of Tri-Service General Hospital and Deputy Director of the Medical Affairs Bureau showcased his strong administrative and operational management skills. The recent completion of the emergency and critical care building at the Armed Forces Taoyuan General Hospital and the upgrade of the National Defense Medical Center to a university further highlight the ongoing advancements and commitment within the military medical system.

“

Strengthen medical resilience, improve medical quality, sustain research and innovation, and expand international exchange.